Metropolis Healthcare Ltd News

Metropolis launches GLP-1 monitoring test packages, targets obesity market

Metropolis Healthcare has rolled out three TruHealth GLP-1 test packages for patients preparing for or undergoing obesity treatment, as diagnostics firms move to tap the fast-growing segment

Metropolis Q2 results: Profit up 13% on higher patient, test volumes

Metropolis Healthcare posted a 13% rise in Q2FY26 net profit to ₹53 crore, driven by increased patient and test volumes, network expansion, and improved performance across regions

Will Apollo, Max, Metropolis outshine peers in Q2? Here's what analysts say

Domestic brokerage firm Nuvama analysts forecast a modest sequential slowdown but a healthy ~17 per cent year-on-year (Y-o-Y) Ebitda growth, led by hospitals and diagnostics.

Metropolis Healthcare rises 4% on releasing Q2 update; check details

According to the company filing, it delivered a 23 per cent year-on-year (Y-o-Y) revenue growth at the consolidated level, driven by robust momentum in preventive health check-ups

Metropolis Healthcare acquires Kolhapur-based pathlab chain for ₹17 crore

Metropolis added that the move is expected to enhance productivity and drive overall profitability across its network of laboratories operating in the region

Stocks to Watch today: Adani Ent, Vedanta, Texmaco, Metropolis, JSW Energy

Stocks to Watch today: Adani group, Vedanta, Texmaco Rail, Metropolis Healthcare, JSW Energy and John Cockerill are among the stocks to watch today, September 19, 2025

Dixon, Metropolis, 2 other stocks flag Buy signal, can rally up to 34%

Technical charts show that Dixon Technologies, Kirloskar Oil Engines, Metropolis Healthcare and RHI Magnesita have witnessed a 'Golden Crossover', hence are likely to see upside in the near-term.

These 2 midcap, 3 smallcap stocks trade in overbought zone; strategy here

Despite trading in overbought territory Delhivery, Metropolis Health look poised for up to 19% further gains, while Usha Martin stock could dip 9%; suggest technical charts.